Literature DB >> 3171613

The need for a new strategy for the treatment of multiple sclerosis.

A N Davison1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171613     DOI: 10.1007/bf00314226

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  35 in total

Review 1.  Immunosuppressant treatment in multiple sclerosis.

Authors:  S van den Noort
Journal:  Clin Neuropharmacol       Date:  1985       Impact factor: 1.592

2.  Effect of methylprednisolone on CSF IgG parameters, myelin basic protein and anti-myelin basic protein in multiple sclerosis exacerbations.

Authors:  K G Warren; I Catz; V M Jeffrey; D J Carroll
Journal:  Can J Neurol Sci       Date:  1986-02       Impact factor: 2.104

3.  Derivation of ganglioside-specific T cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients.

Authors:  A Bellamy; A N Davison; M Feldmann
Journal:  J Neuroimmunol       Date:  1986-08       Impact factor: 3.478

4.  Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.

Authors:  M L Cuzner; A N Davison; P Rudge
Journal:  Ann Neurol       Date:  1978-10       Impact factor: 10.422

5.  The use of cyclophosphamide in the treatment of multiple sclerosis.

Authors:  H L Weiner; S L Hauser; D A Hafler; R J Fallis; J R Lehrich; D M Dawson
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

6.  Neutral protease in cerebrospinal fluid from patients with multiple sclerosis and other neurological diseases.

Authors:  T Inuzuka; S Sato; H Baba; T Miyatake
Journal:  Acta Neurol Scand       Date:  1987-07       Impact factor: 3.209

7.  Chronic relapsing experimental allergic encephalomyelitis: cyclosporin-A treatment of relapsing and remitting disease.

Authors:  A J Suckling; P W Baron; H Reiber
Journal:  J Clin Lab Immunol       Date:  1986-12

8.  Quantitative analysis of the cellular constituents of the cerebrospinal fluid in chronic relapsing experimental allergic encephalomyelitis.

Authors:  A J Suckling; P W Baron; U Mauer; R Burger; M G Rumsby
Journal:  J Neuroimmunol       Date:  1986-03       Impact factor: 3.478

9.  Sensitization of cerebrospinal fluid and peripheral blood lymphocytes to myelin basic protein in multiple sclerosis.

Authors:  A Członkowska; M Półtorak; W Cendrowski; J Korlak
Journal:  Acta Neurol Scand       Date:  1982-07       Impact factor: 3.209

10.  The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.

Authors:  A S Bellamy; V L Calder; M Feldmann; A N Davison
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.